SCHEMBL5819462

SCHEMBL5819462

OC1(c2nc(-c3ccccc3F)c(-c3ccnc(NC4CCCCC4)n3)s2)CCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 7/20 0.40
CCNB1 P14635 7/20 0.40
KDR P35968 2/20 0.40
GSK3B P49841 2/20 0.40
CCNB2 O95067 2/20 0.40
CCNB3 Q8WWL7 2/20 0.40
IRAK4 Q9NWZ3 2/20 0.40
CDC7 O00311 1/20 0.40
PLK4 O00444 1/20 0.40
JAK2 O60674 1/20 0.40
MAP4K4 O95819 1/20 0.40
INSR P06213 1/20 0.40
CSF1R P07333 1/20 0.40
PIM1 P11309 1/20 0.40
PRKACA P17612 1/20 0.40
FLT1 P17948 1/20 0.40
TYK2 P29597 1/20 0.40
FLT3 P36888 1/20 0.40
JAK3 P52333 1/20 0.40
ITK Q08881 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5816357 0.99 RET (0.39) CDK1CCNB1KDRGSK3BCCNB2
SCHEMBL5812866 0.96 MAPK8 (0.39) CDK1CCNB1GSK3BIRAK4MAP4K4
SCHEMBL5818839 0.88 MAPK9 (0.42) CDK1CCNB1CCNB2CCNB3MAPK9
SCHEMBL5812919 0.87 MAPK9 (0.42) CDK1CCNB1CCNB2CCNB3MAPK9
SCHEMBL5818840 0.86 CDK1 (0.39) CDK1CCNB1KDRGSK3BCCNB2
SCHEMBL5818906 0.85 MAPK8 (0.51) KDRGSK3BMAP4K4HIPK2ALK
SCHEMBL5812922 0.85 RET (0.38) CDK1CCNB1KDRGSK3BCCNB2
SCHEMBL5814640 0.85 BRAF (0.47) CDK1KDRGSK3BIRAK4PLK4
SCHEMBL5814974 0.84 BRAF (0.47) KDRMAPK8MAPK9EGFRRAF1
SCHEMBL5819362 0.84 IKBKB (0.41) CDK1CCNB1MAPK8MAPK9CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO claimed
WO-2006137658-A1 NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DONGBU HITEK CO., LTD. (KR) 2006-12-28 WO disclosed